Hot news from the pleura

Hot topics
Chairs: J. van Meerbeeck (Edegem (Antwerp), Belgium), J. Chorostowska-Wynimko (Warsaw, Poland)
Aims: To provide an update on current evidence behind interventional and observational management of pneumothorax, review randomised data on ambulatory care, and improve patient selection for individual interventions; to critically review data to improve practice regarding up-to-date management of patients clear of infection, risk stratification, microbiology and interventions for failing patients; to appraise the evidence for non-chemotherapy management of mesothelioma, including immunotherapy and surgery, provided by recent randomised trial results; to review best practice for management of malignant pleural effusion, patient choice, intervention selection and complication management.
Pneumothorax: rethinking the intervention paradigm
R. Hallifax (Oxford (Oxfordshire), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Pleural infection: phenotyping for optimal treatment selection
N. Rahman (Oxford, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Treating mesothelioma in 2021: what is the role of surgery and immunotherapy?
A. Bibby (Bristol (Avon), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Optimal management of symptomatic malignant pleural effusions: individualised care
E. Grabczak (Warszawa, Poland)
WebcastSlide presentation
WebcastSlide presentation
Discussion and Q&A

Webcast
Webcast